Mestinon (pyridostigmine) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat myasthenia gravis in adults.

Ultomiris (ravulizumab-cwvz) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat generalized myasthenia gravis in adults.

Vyvgart (efgartigimod alfa-fcab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with generalized myasthenia gravis.